Arcturus Therapeutics
ARCT
ARCT
23 hedge funds and large institutions have $17.7M invested in Arcturus Therapeutics in 2019 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.73% more ownership
Funds ownership: 13.58% → 14.31% (+0.73%)
0% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 5
Holders
23
Holding in Top 10
–
Calls
$381K
Puts
$147K
Top Buyers
| 1 | +$1.61M | |
| 2 | +$1.23M | |
| 3 | +$729K | |
| 4 |
NAMA
Nikko Asset Management Americas
New York
|
+$622K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$388K |
Top Sellers
| 1 | -$430K | |
| 2 | -$254K | |
| 3 | -$160K | |
| 4 |
PCM
Prelude Capital Management
New York
|
-$68.5K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
-$38K |